Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the clinical cure of miconazole Lauriad 50 mg (1x50mg) Bioadhesive buccal tablets compared with clotrimazole troches (5x10mg) after 14 days of treatment (at the test of cure visit, at Day 17-19).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Onxeo
• Treatments: Clotrimazole; Miconazole

Criteria

Inclusion Criteria:

• Patients with clinical picture of oropharyngeal candidiasis

• Confirmation of oropharyngeal candidiasis by candida culture positive

• HIV-positive patients

• Patients 18 years of age

Exclusion Criteria:

• Patients with signs or symptoms of systemic candidiasis

• Patients with signs or symptoms of esophagitis

• Pregnant or breast-feeding women

• Patients who have taken systemic antifungals within the past 30 days

• Patients who have taken local antifungals within the past 7 days